Cargando…
Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma
DNA methylation is a key transcription regulator, whose aberration was ubiquitous and important in most cancers including hepatocellular carcinoma (HCC). Whole-genome bisulfite sequencing (WGBS) was conducted for comparison of DNA methylation in tumor and adjacent tissues from 33 HCC patients, accom...
Autores principales: | Huang, Peng, Xu, Mengxiang, Han, Haijun, Zhao, Xinyi, Li, Ming D., Yang, Zhongli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631276/ https://www.ncbi.nlm.nih.gov/pubmed/34858848 http://dx.doi.org/10.3389/fonc.2021.769390 |
Ejemplares similares
-
Integrating the Epigenome and Transcriptome of Hepatocellular Carcinoma to Identify Systematic Enhancer Aberrations and Establish an Aberrant Enhancer-Related Prognostic Signature
por: Huang, Peng, et al.
Publicado: (2022) -
Epigenome-wide analysis of common warts reveals aberrant promoter methylation
por: AL-Eitan, Laith N., et al.
Publicado: (2020) -
Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021) -
A Genome-Wide Investigation of Effects of Aberrant DNA Methylation on the Usage of Alternative Promoters in Hepatocellular Carcinoma
por: Dong, Yuting, et al.
Publicado: (2022) -
Corrigendum: A genome-wide investigation of effects of aberrant DNA methylation on the usage of alternative promoters in hepatocellular carcinoma
por: Dong, Yuting, et al.
Publicado: (2023)